Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Operating Leases (2020 - 2025)

AVITA Medical (RCEL) has disclosed Operating Leases for 4 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 24.82% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Dec 2025, down 24.82%, and an annual FY2025 reading of $2.1 million, down 24.82% over the prior year.
  • Operating Leases was $2.1 million for Q4 2025 at AVITA Medical, down from $2.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $3.1 million in Q3 2024 and bottomed at $306000.0 in Q4 2022.
  • Average Operating Leases over 4 years is $2.1 million, with a median of $2.3 million recorded in 2025.
  • The sharpest move saw Operating Leases soared 456.21% in 2023, then fell 24.82% in 2025.
  • Year by year, Operating Leases stood at $306000.0 in 2022, then skyrocketed by 456.21% to $1.7 million in 2023, then surged by 66.86% to $2.8 million in 2024, then dropped by 24.82% to $2.1 million in 2025.
  • Business Quant data shows Operating Leases for RCEL at $2.1 million in Q4 2025, $2.3 million in Q3 2025, and $2.6 million in Q1 2025.